Incorrect central venous catheter (CVC) tip location can lead to serious and potentially lethal complications; these include malignant arrhythmias and erosion of catheters through the right atrium (RA) or right ventricle, leading to haemothorax, hydrothorax, mediastinal fluid collections or cardiac tamponade 1 . To reduce the risk of tamponade, the most lethal of these complications, the catheter tip should lie in the superior vena cava (SVC) above the cephalic limit of the pericardial reflection (CLPR) 2 . Manufacturers of CVC kits stress the importance of correct CVC tip placement 3 . In the United States, the Food and Drug Administration in 1989 established guidelines regarding this issue 4 , stating "the catheter tip should not be placed in or allowed to migrate into the heart."
Given that CVC insertion is commonplace, published data shows that tip malposition occurs relatively frequently [5] [6] [7] . Previous studies have shown that the use of right atrial electrocardiography (RAECG) or formulae based on patient height 8, 9 can reduce the incidence of CVC tip malposition. However, as the CLPR extends superiorly along the SVC towards the azygos vein, these methods do not eliminate the risk of cardiac tamponade 5 . An issue that previous studies have failed to address is that more proximal placement of multi-lumen CVCs increases the risk of extravasation from the proximal port.
As a Quality Improvement (QI) exercise, we performed a retrospective audit to assess CVC tip position in our cardiac anaesthesia unit. It was, at the time, our unit's practice to insert all triple lumen CVCs to a depth of 15 cm from the skin. In an attempt to reduce the incidence of CVC tip misplacement, a modification of the technique used to determine the depth of catheter insertion was devised, based on the distance between the points of skin insertion and at which venepuncture occurred. The aim of this study was to test the hypothesis that the tailored technique would result in a lower incidence of CVC tip misplacement. examined retrospectively. The first CXR performed on the arrival of each patient to the Intensive Care Unit from the cardiac theatre was reviewed.
The position of the CVC tip relative to a line drawn at the level of the angle between the right main bronchus and the trachea (Figure 1 ) was recorded in millimetres. The CLPR was assumed to be at this level; CVC tips located cephalad to this line were labelled proximal to the CLPR. The SVC/RA junction was assumed to be at the level of a second line drawn 20 mm caudad to the line used to locate the CLPR. CVC tips were considered to be distal to the SVC/RA junction if they were positioned caudad to this second line.
The routine practice in our unit at the time was to use the Seldinger percutaneous technique to insert polyurethane Arrow-Howes Multi Lumen CVC Set Blue flex-tip CS-15703 (Arrow International Inc, Reading, PA, U.S.A.) catheters via the right infraclavicular subclavian route to a depth of 15 cm from the level of the skin (henceforth the "standard technique").
Seventy-three patients scheduled to undergo elective cardiac surgery were then recruited prospectively. Triple lumen CVCs (Arrow-Howes Multi Lumen CVC Set Blue flex-tip CS-15703) were inserted via the right infraclavicular subclavian route using the Seldinger percutaneous insertion technique. In this group, the depth of CVC insertion was determined using a sterile disposable paper ruler to measure the skin to vein distance, this being the distance along the needle at which venepuncture occurred. To this distance was added a further 8 cm, 5 cm being the measured distance between the proximal port and the distal lumen and a further 3 cm acting as a safety margin against accidental catheter migration (henceforth the "tailored technique"). Again, the first postoperative supine CXR was reviewed and the CVC tip position assessed.
CVCs were inserted by a Staff Specialist cardiac anaesthetists or a Registrar in Cardiac Anaesthesia in both groups.
In all patients, weight, height, body surface area (BSA) and the depth of CVC insertion from the skin were recorded. Complications resulting from CVC insertion were noted.
CVC tip position was compared in the two groups using the Chi-squared test. The Student's t test (assuming equal variances) was used to compare the depth of CVC insertion between the groups. The correlation coefficients for depth of CVC insertion with weight, height and BSA were determined for the group in which the tailored technique was used. Pearson's correlation coefficient was used for this calculation. P values <0.05 were considered significant.
RESULTS
Demographic data are presented in Table 1 . The groups were similar with regard to age, weight, sex, height and BSA. The CVC tip location using the standard and tailored techniques for determining depth of CVC insertion are given in Figure 2 and in Table 2 . The proportion of CVC tips distal to the SVC/RA junction was greater in the standard group 
DISCUSSION
Factors involved in cardiac tamponade in association with CVC insertion include percutaneous dilator or guidewire penetration during insertion, catheter tip location, catheter stiffness, angle of the catheter to the vessel wall, tonicity of solutions infused and catheter movement. We aimed to evaluate a simple technique for CVC insertion to ensure the safest location for the catheter tip, further reducing the likelihood of this rare lethal complication and others such as cardiac arrhythmias, whilst minimizing the risk of extravasation from the proximal port of the multi-lumen CVC and complying with current guidelines [3] [4] . The risk of cardiac tamponade from CVC tip erosion can only be present if the catheter tip is below the cephalic limit of the pericardial reflection. Neither the CLPR nor the RA are easily identified on the anterior-posterior (AP) supine CXR. Anatomically, the CLPR is located at the junction of the azygos vein and the SVC which lies in the angle made by the right main bronchus and the trachea (Figure 1 ). This position has previously been described by Rutherford et al 5 . The SVC/RA junction can be approximated as 20 mm below the CLPR.
Tailoring the depth of CVC insertion to the individual patient results in a greater proportion of CVC tips being satisfactorily positioned. Significantly fewer CVC tips were located caudad to the CLPR and into the RA when the depth of insertion was determined by the tailored method compared to inserting all CVCs to a depth of 15 cm at the skin (P<0.001).
When the CVC tip was caudad to the SVC/RA junction, the degree of overinsertion was less in the tailored group (P<0.001). However, despite the reduced depth of insertion, 9 of 73 (12%) catheter tips were located below the SVC/RA junction.
No significant correlation for height, weight or BSA with depth of CVC insertion could be demonstrated. This suggests that tailoring the depth of CVC insertion to the individual is useful, as one cannot use physical attributes of the patient to predict to what depth the CVC should be inserted. It follows that the distance from the skin at which venepuncture occurs is therefore a useful guide, and indeed is a principle used in guiding epidural catheter insertion.
Using the tailored method, the majority of CVCs were inserted to a depth less than 15 cm. The average depth of insertion (13.2 cm) was less than that used previously in our unit. More importantly, the greatest depth of insertion (15 cm) was that which had been previously used as routine.
On the basis of this study, no particular depth of insertion can be recommended for routine use. Rather, the depth of insertion should be determined in a similar fashion to the placement of an epidural catheter where the skin-to-space distance is measured. Provision within CVC kits of a venepuncture needle with gradations every one centimetre would facilitate this technique.
A potential problem when using our technique in obese patients is that the skin and subcutaneous tissues may need to be indented before venepuncture is encountered. In this instance when the tension on the subcutaneous tissues is released, the measurements as calculated may be inaccurate.
Previous studies addressing the issue of radiological confirmation of CVC tip position often do not define how tip location relative to the right atrium was determined 6, 7, 9 . The CXR taken after CVC insertion is often an AP supine film. Bony landmarks, which may be used in the posterior-anterior CXR 2 , cannot be used to identify CVC tip position on the AP CXR as they are subject to considerable error induced by parallax 5 . The SVC/RA junction cannot be identified with certainty on an AP CXR ( Figure 1 ) and in any case, the ideal location for the tip is proximal to the CLPR if the risk of cardiac tamponade is to be eliminated. This study has demonstrated the benefits of performing QI and attempting corrective measures. Our tailored method of determining CVC insertion depth has several advantages over previously used methods. Firstly, the CVC is always inserted to the minimum safe depth in order to avoid extravasation via the proximal port and limit overinsertion. If the catheter is inadvertently inserted to pass retrograde into the internal jugular vein, this distance is also minimized. Secondly, it takes into account different operator insertion techniques compensating for variations in the location of the skin puncture.
Right atrial electrocardiography has been shown to be a reliable technique to avoid RA cannulation 6, 7 . Our tailored technique avoids several problems which may occur when using right atrial electrocardiography, as with the latter technique, there is concern that the proximal port of multi-lumen catheters is not definitely intraluminal. Using our tailored method, 3cm of outward catheter migration must occur before the risk of extravasation is present. The tailored technique also avoids the risk of microshock since a normal saline column is not used. It is also faster and no special equipment is necessary. Identifying the RA using electrocardiography will avoid RA cannulation, but will not eliminate the potential hazard of cardiac tamponade as the CVC tip may still lie between the RA and the CLPR.
Manufacturers warn only against right atrial placement. Locating the CLPR as the ideal reference point for CVC tip position will eliminate the potential for cardiac tamponade unless distal catheter migration were to occur. It is then apparent that if one is to allow a safety margin of 3.0 cm against accidental proximal catheter migration, in some individuals multi-lumen catheters will have to be located beyond the CLPR and even into the right atrium to avoid extravasation via the proximal port. Minimizing the distance between the most proximal and the most distal ports will reduce the potential for extravasation to occur whilst facilitating CVC tip placement proximal to the RA. Enough distance between ports of a triple lumen CVC must be allowed to avoid adverse drug interactions. It should be noted that the distance between the most proximal and most distal ports varies between different makes of catheter.
It may be that the fear of extravasation results in many multi-lumen CVCs being inserted too far distally. Although securing techniques are a matter of personal preference, perhaps future studies should be aimed at avoiding catheter migration and in developing techniques that minimize catheter movement.
Other guidelines have been suggested in the literature. Recommendations that the safe depth of insertion be limited to 20 cm or less 48 , 18 cm or less 49 or that the average safe insertion depth for a CVC from the internal jugular or subclavian vein is 16.5 cm for the majority of patients 7 , seem excessive. In our study, the mean depth of insertion was 13.2 cm and ranged between 11.5 cm and 15.0 cm using the tailored technique. Even then, right atrial placement occurred in 9/73 cases. Given that CVCs can be more easily secured to the skin if they are inserted to their hub (to limit catheter migration ), the routine use of CVCs longer than 15 cm should be questioned.
Others have suggested that patient height is useful in determining the depth of CVC insertion 8, 9 . The use of such formulae do not allow for variations in skin puncture sites by different operators. We did not demonstrate a significant relationship between patient height and depth of CVC insertion using the tailored method.
Since polyurethane and silastic have replaced the stiffer polyethylene multi-lumen CVCs, the incidence of vessel perforation, based on the paucity of case reports and information provided by manufacturers, is extremely low. The exact incidence is not known as reporting to relevant authoritative bodies such as the Therapeutic Goods Administration is voluntary. In addition, vessel perforation is a well recognized complication of CVCs and its occurrence would not necessarily lead to the submission of case reports to journals 10 . Nevertheless, 66 cases of cardiac tamponade following CVC insertion (excluding dialysis catheters and longterm catheters, e.g. Hickman catheters) have been reported over the last twelve years. The reports describe perforation of the SVC, RA and the right ventricle by CVCs including silastic [11] [12] [13] [14] [15] [16] [17] [18] [19] and polyurethane [20] [21] [22] [23] [24] [25] catheters inserted for short periods (minutes to hours) and over the longer term in neonates 11, [15] [16] [17] [18] [19] 20, [27] [28] [29] [30] [31] , children 12, 14, 24, 32, 33 and adults 12, 13, 20, 21, 23, 24, 31, [34] [35] . Of these case reports, 44 (67%) related to CVC insertion in patients over 12 years of age 12, 13, 20, 21, [23] [24] [25] 31, [34] [35] and thirty (68%) of these 44 cases were fatal. An additional three patients were left in a persistent vegetative state after resuscitation.
The manufacturer of the CVC and the material used were specified in only 12/44 cases 20, 21, 24, 30, 40 . In the remainder, the material type was mentioned in 10/44 cases but not the manufacturer 12, 13, 23, 25, 38, 39, 42, 43 . Neither the manufacturer nor the material were reported in half (22/44) of the case reports 31, 34, 35, 37, 41, 44, 45 . Seven catheters were polyethylene 36, 38, 42, 43 , one PVC 39 , five silicone 12, 13 , two teflon 24 and seven 64 polyurethane 20, 21, 23, 24, 25, 40 . It is necessary to include the name of the manufacturer, as not only does catheter stiffness differ between different makes of CVCs, it may also differ between those composed of the same material by the same manufacturer 46, 47 . This may allow identification of those catheters posing a greater clinical hazard than others with respect to risk of vascular and cardiac perforation.
Cardiac tamponade does occur as a rare complication of CVC insertion, it can be lethal and its risk can be reduced by better placement strategies. Equally, extravasation of fluids infused through multi-lumen catheters can have devastating results. Therefore it is important to ensure appropriate positioning of CVCs. Simple techniques such as the one described above help avoid catheter tip misplacement. Future case reports published regarding central venous catheters and vessel or heart perforation should state the name of the manufacturer and the material used to allow for the evaluation of the relative safety of the different catheter material types in vivo.
